Patrick Clysdale Joins Direct Sales Team at Herculite Products

Herculite Products is pleased to announce that Patrick Clysdale has been hired as
the Southeastern Regional Manager for the Direct Sales Team. Herculite is excited to expand its sales team to support and continue the strong growth in that market.

Patrick Clysdale will manage the company’s Direct Sales team’s southeastern region, which includes automotive, custom-engineered solutions, healthcare, agriculture, and tent and structure customers.

Herculite strives to be the most responsive, supportive, and educated sales force in the industry, and Patrick’s addition to our team will help us continue to achieve that goal.

Patrick comes to Herculite with nearly 10 years of experience in B2C sales support and over four years in B2B distribution. A collegiate baseball player, Patrick brings a strong history of
teamwork and competitive skills to the Herculite Direct Sales Team. Patrick lives in Florida and enjoys spending quality time with family, including his 10-month-old daughter.

Hot this week

Cartessa Aesthetics Partners with Classys to Bring EVERESSE to the U.S. Market

Classys, which is listed on the KOSDAQ, is one of South Korea's most distinguished aesthetic technology manufacturers, with devices distributed in 80+ markets globally. This partnership marks Classys's official entry into the American marketplace, with Cartessa Aesthetics as the exclusive distributor for EVERESSE, launched under the Volnewmer brand in current global markets.

Stryker Launches Next-Generation of SurgiCount+

Now integrated with Stryker's Triton technology, SurgiCount+ addresses two key challenges: retained surgical sponges and blood loss assessment. Integrating these previously separate digital solutions provides the added benefit of a more efficient, streamlined workflow for hospitals notes Stryker.

Nevro Receives CE Mark In Europe for It’s HFX iQ™ Spinal Cord Stimulation System

Nevro notes HFX iQ is the first and only SCS system with artificial intelligence (AI) technology that combines high-frequency (10 kHz) therapy built on landmark evidence that uses ongoing cloud data insights to deliver personalized pain relief

Recor Medical Reports: CMS Grants Distinct TPT Device Code and Category to Recor Medical for Ultrasound Renal Denervation

The approval of TPT offers incremental reimbursement payments for outpatient procedures performed with ultrasound renal denervation for Medicare fee-for-service beneficiaries. It becomes effective January 1, 2025, and is expected to remain effective for up to three years notes Recor Medical.

Jupiter Endovascular Reports | 1st U.S. Patient Treated with Jupiter Shape-shifting Thrombectomy Device

“Navigation challenges during endovascular procedures are often underappreciated and have led to under-adoption of life-saving procedures, such as pulmonary embolectomy. We have purpose-built our Endoportal Control technology to solve these issues and make important endovascular procedures accessible to more clinicians and their patients who can benefit from them,” said Carl J. St. Bernard, Jupiter Endovascular CEO. “This first case in the U.S. could not have gone better, and appears to validate the safety and performance we are seeing in our currently-enrolling European SPIRARE I study.”